Hercules Capital, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Hercules Capital, Inc. (NYSE: HTGC) is a business development company (BDC) that provides venture lending and growth capital to innovative, high-growth companies, primarily in technology, life sciences, and sustainable/renewable technology-enabled sectors. The company offers a diversified portfolio of customized financing solutions, including senior secured loans; unitranche loans; mezzanine debt; equity investments; and warrant and equity-related securities, often structured as first- and second-lien loans with warrants for upside participation. Hercules targets late-stage venture-backed companies and underserved middle-market firms, operating principally in the United States with a focus on U.S.-based portfolio companies across software, internet, healthcare, and clean tech industries. Founded in 2003 and headquartered in Palo Alto, California, Hercules Capital manages approximately $4 billion in assets under management as of late 2025, serving as a leading non-bank lender to the venture ecosystem. The company structures its investments to provide flexible capital for growth initiatives such as mergers and acquisitions, product development, and international expansion, while maintaining rigorous due diligence and active portfolio management. It operates through subsidiaries like Hercules Capital Funding I, LLC, and has no parent company, functioning as an independent publicly traded BDC regulated under the Investment Company Act of 1940. In recent developments, Hercules Capital completed several strategic portfolio expansions in 2024 and 2025, including new debt and equity investments in high-profile tech firms such as those in AI infrastructure and biotech, bolstering its portfolio diversification amid rising interest rates. The company announced a key partnership with leading venture capital firms in Q3 2025 to co-invest in Series D and later-stage companies, enhancing deal flow and risk mitigation. Additionally, Hercules raised capital through an at-the-market equity offering program in early 2025, funding over $300 million in new originations and supporting dividend sustainability with a payout ratio under 90%.
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call
Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet
Hercules Capital: This 12% Yield Is My Top Pick For The Back Half
Hercules Capital Faces Its Own 12 Labors
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note
A $310,000 Portfolio That Pays More Than the Rent on a Big-City East Coast Studio Apartment
Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C
Hercules Capital: Attractive Valuation And Growth Potential
Hercules Capital (HTGC) Down 7.4% Since Last Earnings Report: Can It Rebound?
My Dividend Stock Portfolio: New April Dividend Record - 100 Holdings With 5 Buys
The High-Yield Stocks the Smart Money Is Buying Right Now
Hercules Capital: Buy The Dip On This 12% BDC Yield
HTGC DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Hercules Capital, Inc. Investors to Secure Counsel Before Important May 19 Deadline in Securities Class Action - HTGC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hercules Capital, Inc. of Class Action Lawsuit and Upcoming Deadlines – HTGC
Bronstein, Gewirtz & Grossman LLC Urges Hercules Capital, Inc. Investors to Act: Class Action Filed Alleging Investor Harm